Authors

The Role of the Pharmacist in the Management of Psychosis in Parkinson Disease

Pharmacists optimize dopaminergic therapy, mitigate medication-induced psychosis, and guide antipsychotic selection to improve outcomes in Parkinson disease psychosis.

Study: Maternal Asthma Increases Incidence of Adverse Perinatal Outcomes

Implementing Datopotamab Deruxtecan in Practice: TROPION Insights

Measles on the Move: Guidance for Pharmacists During Outbreaks

Between December 22, 2024, and March 7, 2025, reported measles cases in the US climbed precipitously.

New Jersey Society of Health-System Pharmacy Hosts 2nd Annual Pharmacy Leader and Pharmacy Technician Symposium

The NJSHP's 2nd Annual Symposium fosters networking and education for pharmacy professionals, featuring expert insights on compliance and regulation in pharmacy compounding.

Bridging the Gap: Field Teams and Hubs Supporting Patient Care

Enhanced communication between field representatives and case managers improves medication access for patients with rare diseases.

Beyond the Dispensing Counter: Community Service and Volunteerism Spur Growth

Volunteer service strengthens pharmacists’ empathy, confidence, and communication, boosting patient trust, teamwork, and community connection.

Type 2 Diabetes Medication Adherence Rates Remain Low—And Pharmacists Can Help

Adherence to glucose-lowering drugs ranges from 41% to 68% depending on drug class.

Navigating Pediatric Atopic Dermatitis: Insights Into Treatment, Challenges, and Care Considerations

Atopic dermatitis significantly impacts quality of life, and requires personalized management through trigger identification, skin barrier maintenance, and a range of topical, oral, and biologic therapies to reduce symptoms and prevent flare-ups.

Advancing Anaphylaxis Treatment With Needle-Free Epinephrine Delivery

Intranasal epinephrine spray offers a needle-free option for anaphylaxis treatment.

Bridging the Gap: Field Teams and Hubs Supporting Patient Care

Enhanced communication between field representatives and case managers improves medication access for patients with rare diseases.

Risks and Impacts of Cannabis Use During Pregnancy: A Growing Concern for Neonatal Health

Cannabis use during pregnancy may harm fetal development and long-term health.

As Peptides Go Mainstream, USP <795> and <797> Matter More Than Ever

Peptide compounders face rising scrutiny as regulators and lawsuits zero in on adherence to established compounding standards.

Vaccination Conversations: Mastering Patient Q&A at the Pharmacy

When you’re unsure about answering a patient question, err on the side of caution and refer them to a pharmacist.

Pharmacists Can Advance Immunomodulatory Care in Multiple Myeloma

Pharmacists can play a pivotal role in overcoming the many challenges that exist in accessing immunomodulatory drugs in multiple myeloma.

Hypertension: A Silent Killer Requiring Novel Therapies

Hypertension is widespread and linked to serious health risks, but new treatments for resistant cases target new mechanisms of action.

Not A Laughing Matter: Emerging Nitrous Oxide Regulatory Oversight

Laughing gas misuse is surging as nitrous oxide drug abuse spreads online

Flushing the Old Away: Transitioning From Heparin to Saline for Implanted Port Maintenance

This abstract was presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 18 to 19, 2026.

Afamitresgene autoleucel: The First T-Cell Receptor Therapy on the Market

Second-line and later treatment options for synovial sarcoma are limited. Afamitresgene autoleucel is the first FDA-approved T-cell receptor therapy, demonstrating long-lasting responses and tolerable adverse effects in pretreated patients.

From Quick Wins to Long-Term Infrastructure: A Pharmacist's Roadmap for Antithrombotic Stewardship

Darren Triller, PharmD, walks through the relative ease and impact of each of the 5 ADAPT priority areas, makes the case for dashboard-driven population health management.

A Student Pharmacist’s Guide to HIV Medications

Pharmacy students must have a comprehensive understanding of antiretrovirals to ensure efficiency and optimization of patients’ medical treatment.

How AON Built an Outpatient BiTE Therapy Program for Multiple Myeloma

In an interview with Pharmacy Times, Nicole McMullin, regional clinical pharmacist at American Oncology Network, discussed AON’s development of an all-outpatient approach to step-up dosing for bispecific T-cell engager therapy in multiple myeloma.

OTC Naloxone Expands Access, but Cost and Distribution Gaps Still Limit Overdose Prevention

In an interview with Pharmacy Times, Alison Newman, MPH, program operations specialist with the Center for Community-Engaged Drug Education, Epidemiology & Research at the Addictions, Drug & Alcohol Institute at the University of Washington, discusses the significance of OTC naloxone availability and the barriers that remain despite the introduction of additional products.

From the Infusion Chair to the System Level: What Nearly Losing My Life Taught Me About Site-of-Care Decisions

Subcutaneous Olanzapine in Schizophrenia: Expanding a Proven Therapy's Utility

TV-44749 is a subcutaneous long-acting injectable form of olanzapine that is effective in schizophrenia while avoiding risks seen with the intramuscular formulation.

Addressing Burnout in Pharmacy Residency: A Comprehensive Approach to Enhancing Well-Being

Initiatives aim to reduce residents' high rates of depression and increase self-care skills.

Insights From HOPA 2025: Pharmacists Discuss CAR-T Safety at a Comprehensive Cancer Center

Amir Ali, PharmD, BCOP, and Allison Hsieh, PharmD share insights from their presentation about cytokine release syndrome, ICANS, and CAR T-cell therapy.

Oral Semaglutide Approved to Reduce the Risk of Cardiovascular Events

The FDA approved oral semaglutide to reduce the risk of major adverse cardiovascular events (MACE) in patients with type 2 diabetes (T2D).

Apixaban vs Rivaroxaban: A Clearer Choice for VTE?

Although evidence supports safety of apixaban and rivaroxaban relative to warfarin, researchers had not directly compared their bleeding risk until last year.